INTRODUCTION
The impact of depression on the development and prognosis of chronic diseases, coronary heart disease (CHD) in particular, has attracted significant research attention in recent years. In healthy populations, long-term prospective studies have found depression to be associated with the development of CHD, independently of other risk factors for CHD. , , Successive meta-analyses show [1 2 3 ] depression to increase the risk for the onset of CHD, with pooled relative risk between 1.6 and 1.8 in subjects with diagnosed depression or those reporting depressive symptoms. , , Several other studies have shown that depression is also associated with increased risk of [1 4 5 ] all-cause and cause-specific mortality in general populations. , , , Furthermore, there is increasing evidence of the importance of [3 6 7 8 ] depression as a prognostic factor as the outcomes of myocardial infarction (MI) have been found to be worse among depressive than Heart . Author manuscript Page / 2 11 non-depressive MI-patients after controlling for cardiac disease severity. , , Findings from two recent systematic reviews have [9 10 11 ] shown that in individuals with established CHD, depression is associated with an approximately 2-fold higher risk of death from all-cause and cardiac mortality. , [12 13 ] However, these studies typically compared depressed and non depressed participants free of CHD or depressed and non depressed patients with CHD. This approach does not allow comparisons across risk-factor groups based on the cross-classification of depression and CHD status, and it remains uncertain whether the effect of depression on mortality in individuals with CHD is larger than that in healthy individuals. The present investigation was therefore conducted to examine effects of depressive symptoms and coronary heart disease and their interactive associations on mortality in middle-aged adults. We examined whether the association between depression and mortality varied among individuals with both CHD and depressive symptoms compared to those: 1) without both these conditions, 2) with depressive symptoms but not CHD, and 3) with CHD but no depressive symptoms.
MATERIAL & METHODS
Data are drawn from the Whitehall II study, established in 1985 as a longitudinal study to examine the socioeconomic gradient in health and disease among 10,308 civil servants (6,895 men and 3,413 women). All civil servants aged 35 55 years in 20 London based examination Phases 3 (1991 1993), 5 (1997 1999) and 7 (2002 2004) . Depressive symptoms were assessed by the Center for
Epidemiologic Studies Depression Scale (CES-D) for the first time at phase 7 and this phase serves as the baseline for the present study.
The University College London ethics committee approved the study.
Measures

Coronary heart disease (CHD)
CHD status at phase 7 was defined as non-fatal MI or definite angina and was based on clinical examinations at phases 1, 3, 5, and 7
' ' and records obtained from general practitioners and hospitals. Potential non-fatal myocardial infarction was ascertained by questionnaire items on chest pain (the World Health Organisation Rose questionnaire. ) and physician diagnosis of heart attack. Confirmation of [14 ] myocardial infarction according to MONICA criteria (Multinational Monitoring of Trends and Determinants in Cardiovascular [15 ] Disease) was based on electrocardiograms, markers of myocardial necrosis, and chest pain history from medical records. Angina was assessed based on participant s reports of symptoms with corroboration in medical records or abnormalities on a resting electrocardiogram, ' an exercise electrocardiogram, or a coronary angiogram.
Depressive symptoms
Depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale (CES-D, Cronbach alpha 0.83) at = phase 7 of the Whitehall II study (2002 2004 ). The CES-D, a widely used and validated instrument, is a 20-item self-report questionnaire designed to measure depressive symptomatology in community studies. A score 16 from a total possible score of 60 has been used [16 ] ≥ extensively to distinguish depressed from nondepressed subjects . [16 ] 
Vital status
Mortality follow-up was available through the National Health Services Central Registry until 30 April 2009. Death certificates were th coded using the 10 revision of the International Classification of Disease (ICD). All-cause mortality was the main outcome, in subsidiary th analysis we also analysed death from cardiovascular diseases (CVD; ICD-10 codes I20 I25 and I60 I67).
--
Covariates
Sociodemographic measures
Sociodemographic measures included age, sex, ethnicity, and socioeconomic position (SEP) assessed by British civil service grade of employment taken from the phase 7 questionnaire.
Biobehavioural risk factors
Behavioural CVD risk factors were assessed using responses to the phase 7 questionnaire and categorised as follows: smoking status (never, ex, and current), physical activity ( 1.5 or <1. Resting heart rate (RHR) was measured at the phase 7 screening clinic via electrocardiogram (ECG) from participants in the supine position following a standard protocol. The following classification was used to categorise RHR: RHR<80, and RHR>80 beats/minute (bpm).
Antidepressant medications
Data on antidepressant medications was drawn from the phase 7 questionnaire where participants were asked whether in the last 14 days they had taken antidepressants drugs prescribed by a doctor (yes/no).
Cardiovacular disease medications
CVD medications at phase 7 were also drawn from questions on whether in the last 14 days the participant had taken CVD drugs, including diuretics, beta blockers, ACE inhibitors, calcium channel blockers, other anti-hypertensive, prescribed by a doctor (yes/no).
Statistical analysis
We divided the study sample into 4 risk-factor groups based on the cross classification of depression (depression (CES-D 16) vs. no ≥ depression (CES-D <16)) and CHD (yes/no) at phase 7. Differences in these risk-factor groups as a function of the sample characteristics were assessed using a chi-square test
The risk of death was examined using Cox regression in 5 serially adjusted models, with participants without depressive symptoms and CHD constituting the reference group. Model 1 included adjustment for sex and age and Model 2 was additionally adjusted for ethnicity and SEP. Model 3 was as model 2 but additionally adjusted for smoking, BMI, alcohol consumption, physical activity, hypertension, total cholesterol, diabetes, and RHR. Model 4 was as model 2 plus adjustment for CVD medications and antidepressant medications. Finally, model 5 was the fully adjusted model with simultaneous adjustment for all covariates. In further analysis we changed the reference group and repeated these analyses in order to estimate the risk of death for participants with both depressive symptoms and CHD in comparison to those with depressive symptoms but without CHD and to those with CHD but without depressive symptoms. The time-dependent interaction terms between each predictor and logarithm of follow-up period were all non-significant confirming that the proportional hazards assumption was justified.
To examine whether the coexistence of depressive symptoms and CHD increased risk of death beyond that associated with each of them alone we tested for an interaction on the additive scale as defined by Rothman for calculating the relative excess risk due to [17 ] interaction (RERI) using the methods outlined by Andersson et al. . In the absence of an interaction between depressive symptoms and [18 ] CHD, the RERI is 0. RERI and the associated 95 CIs were computed by the delta method.
% [19 ]
RESULTS
Of the 10308 participants of the Whitehall II Study, the current analysis where the follow-up starts at Phase 7 of the study is based on a total of 5936 participants. Those not included in the analyses due to missing data were more likely to be: women (39.9 vs. 28.1 , shows the baseline characteristics of the study participants. Participants with both depressive symptoms and CHD, as Table 1 compared to those free of both conditions, were older and more likely to be from low socioeconomic position, non-White, antidepressant users, current smokers (along with those depressed participants without CHD), less physically active, obese, diabetic, treated by CVD medication and less likely to have high total blood cholesterol (all 0.009). As expected, results from additional analyses conducted p ≤ separately for depression and CHD (data not shown in table), revealed that they both were associated with all cause mortality, the age-sex-adjusted hazards ratios (HRs) being 2.41 ( <0.001) and 2.02 ( <0.001) respectively. The corresponding HRs for CVD mortality p p were 2.83 ( 0.001) and 2.61 ( 0.004). p = p = presents the HRs for the associations with mortality, from all-causes and from CVD, in the groups resulting from the cross Table 2 classification of CHD and depressive symptoms. Model 1 shows that compared with participants without CHD and depressive symptoms (the reference group) the age-and sex-adjusted hazard ratio for death from all-causes was higher in all three exposed groups: those with depressive participants but not CHD (1.67, 95 confidence interval (CI) 1.05 2.66), those with CHD but not depression (2.10, 95 CI participants who were depressed but without CHD no substantial risk reduction was observed (HR 2.37, 95 CI 1.07 5.34).
= % presents the risk of mortality, first all cause and then CVD mortality, among participants who were depressed and had CHD Figure 1 compared to those who were depressed but free from CHD. These results show 2.4-fold (p<0.006) and 2.7-fold higher (p 0.08) risk for all = cause and CVD mortality respectively when adjustments were made for sex and age. Serial multivariable adjustment substantially attenuated these associations leading to non-significant associations for all-cause mortality (HR 1.66, 0.13), and for CVD mortality = p = (HR 1.65, 0.40).
= p =
For results presented in , the reference category is set to the group of individuals with CHD but no depressive symptoms. In Figure 2 model 1 (age and sex adjusted) the HRs associated with co-existing depression and CHD were 2.99 ( 0.001) and 2.92 ( 0.06) for all p = p = cause and CVD mortality, respectively. Serial multivariable adjustment showed no substantial attenuation for these associations. 
DISCUSSION
In this prospective study we sought to evaluate the differential effects of depressive symptoms on all-cause and CVD mortality in a large sample of middle-aged participants, with and without established CHD. We created 4 risk-factor groups based on the cross classification of depressive symptoms (yes/no) and CHD status (yes/no) at baseline. Our results show that compared to participants without depressive symptoms and CHD, the fully adjusted risks of mortality from all-cause and CVD were 2.9-fold and 3.9-fold higher for participants with both CHD and depressive symptoms, respectively. Further comparisons also indicated that the risks of death from all-causes and CVD were higher, but to a lesser extent, for these participants when specifically compared to those with depressive symptoms only or CHD only. There is some evidence of an additive interaction between depressive symptoms and CHD for mortality.
Findings in context of the literature
Several studies have examined the effect of depression on all-cause and CVD mortality in community and patients populations. Our ' results are in line with the findings reported in those studies. , , , , , However, an important contribution of the present [3 6 9 10 11 20 ] study to the current literature is that it is one of the first prospective cohort studies to compare the effects of depressive symptoms for mortality in individuals as a function of their CHD status. Our findings are based on a large well-characterized cohort with depressive symptoms assessed using a validated scale and biological risk factors assessed during a clinical examination. CHD events were ascertained using medical records and electrocardiograms data from clinical examinations. We were able to compare, within the same study, participants with both depressive symptoms and CHD to those free of one or both these conditions. We found fairly similar pattern of associations for both mortality outcomes examined, reinforcing therefore our confidence in the internal validity of our findings.
In the present study, the co-occurrence of depressive symptoms and CHD is associated with an increased risk of all-cause and CVD mortality beyond that due to depressive symptoms and CHD alone. The estimates for the additive interactions largely exceeded the value 0 (absence of interaction), even if the 95 confidence intervals for the RERIs were wide, particularly for CVD mortality. Indeed, we found % that the RERI between depressive symptoms and CHD for all-cause mortality was 3.58 (4.61 for CVD death), suggesting that the relative risk of death from all-cause in depressive participants with CHD is 3.58 (4.61 for CVD death) more than if there were no interaction.
In order to test the robustness of our findings we repeated the main analysis by only considering participants with confirmed MI as CHD cases (see ). Similar pattern of associations were observed as those presented in the main analysis in which CHD online appendix cases were participants with both confirmed MI and definite angina. This suggests that the combined effect of depressive symptoms and CHD on mortality outcomes is not sensitive to the definition of CHD events.
Further comparisons across risk-factor groups revealed ( and ) that participants with both depressive symptoms and CHD figures 1 2 were 2.4-fold (2.7-fold) and 3-fold (2.9-fold) higher age-sex-adjusted risk of all-cause (CVD) death when compared to those with only depression and only CHD, respectively. In combination, these observations illustrate the importance of the choice of the comparison group when estimating the effect size of depressive symptoms on health outcomes. The choice of the reference group seems also to be of great importance when testing the mediating role of third variables in the association between depression, morbidity and mortality. For instance the percentage of reduction in the age-sex adjusted hazards of death outcomes after multivariable adjustments for depressive participants with CHD varied from 49 to 51 , 53 to 62 , and 0 to 16 when compared to those without either depressive symptoms or CHD (
, those with only depressive symptoms ( ) and those with only CHD ( ), respectively. table 2  figure 1  figure 2 Adjustment for sociodemographic characteristics, biobehavioural risk factors, antidepressant and CVD medications attenuated the increased risk of death in participants with only CHD towards the null, suggesting that this association was attributable to differences in baseline characteristics between the groups. However, this was not the case in those participants with only depressive symptoms and in those with both depressive symptoms and CHD, suggesting that the mechanisms through which depressive symptoms increase the risk of all-cause and CVD death remain to be understood. Further studies should explore other possible mechanisms that have not been addressed in the present study, including for example inflammatory processes , platelet activation , endothelial dysfunction , [21 ] [22 ] [23 ] polyunsaturated fatty acids and plasma lipoproteins metabolism , and the role of non adherence to medical regimens , . 
Study limitations
In interpreting the present results, it is important to note some limitations. First, this cohort of civil servants did not include blue collar workers, unemployed or individuals with precarious jobs and younger adults; thus it is not representative of the general population, which may limit the generalisability of our findings. Second, we assessed depressive symptoms rather than clinical depression. However, it has been suggested that significant depressive symptomatology could be a risk factor for clinical depression . Finally, as we had only 15 [16 ] all-cause and 5 CVD deaths in the group of participants with both depressive symptoms and CHD, lack of statistical power is likely to be the main reason why the RERI values, though large, did not reach statistical significance.
Conclusions and implications
Despite these potential limitations, the present findings remain important by providing evidence that depressive symptoms are associated with an increased risk of all-cause and CVD death and that this risk is particularly marked in depressive participants with co-morbid CHD. A major implication of these results is the need for health care professionals to pay more attention to depression in their cardiac patients. Approximately 20 of participants with a history of CHD in our study had depressive symptoms, a figure consistent with % those from previous studies estimating the prevalence of minor and major depression in patients with established CHD to be 27 and 20 , % % respectively , . The findings stress the importance of developing interventions that are effective in reducing mortality due to [28 29 ] depression. It should be noted that the mechanisms through which depressive symptoms increase mortality need to be better understood before evidence-based interventions can be developed.
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